Document Detail

The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems.
MedLine Citation:
PMID:  17308048     Owner:  NLM     Status:  MEDLINE    
A major limitation of adenovirus type 5-mediated cancer gene therapy is the inefficient infection of many cancer cells. Previously, we showed that treatment with low doses of the histone deacetylase inhibitor FK228 (FR901228, depsipeptide) increased coxsackie adenovirus receptor (CAR) levels, histone H3 acetylation, and adenovirus infection efficiencies as measured by viral transgene expression in cancer cell lines but not in cultured normal cells. To evaluate FK228 in vivo, the effects of FK228 therapy in athymic mice bearing LOX IMVI or UACC-62 human melanoma xenografts were examined. Groups of mice were treated with FK228 using several dosing schedules and the differences between treated and control animals were determined. In mice with LOX IMVI xenografts (n = 6), maximum CAR induction was observed 24 h following a single FK228 dose of 3.6 mg/kg with a 13.6 +/- 4.3-fold (mean +/- SD) increase in human CAR mRNA as determined by semiquantitative reverse transcription-PCR analysis. By comparison, mouse CAR levels in liver, kidney, and lung from the same animals showed little to no change. Maximum CAR protein induction of 9.2 +/- 4.8-fold was achieved with these treatment conditions and was associated with increased histone H3 acetylation. Adenovirus carrying a green fluorescent protein (GFP) transgene (2 x 10(9) viral particles) was injected into the xenografts and GFP mRNA levels were determined. A 7.4 +/- 5.2-fold increase in GFP mRNA was found 24 h following adenovirus injection into optimally FK228-treated mice (n = 10). A 4-fold increase in GFP protein-positive cells was found following FK228 treatment. These studies suggest that FK228 treatment prior to adenovirus infection could increase the efficiency of adenovirus gene therapy in xenograft model systems.
Merrill E Goldsmith; Alian Aguila; Kenneth Steadman; Alfredo Martinez; Seth M Steinberg; Michael C Alley; William R Waud; Susan E Bates; Tito Fojo
Related Documents :
11021638 - Histone deacetylase inhibitors and cell proliferation in pea root meristems.
16818788 - Dynamic and transient remodeling of the macrophage il-10 promoter during transcription.
1637418 - Expression of the murine homologue of the cell cycle control protein p34cdc2 in t lymph...
17713478 - Utx and jmjd3 are histone h3k27 demethylases involved in hox gene regulation and develo...
3024708 - Half-life of synovial cell collagenase mrna is modulated by phorbol myristate acetate b...
23696868 - Enhanced translation of mrnas encoding proteins involved in mrna translation during rec...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural    
Journal Detail:
Title:  Molecular cancer therapeutics     Volume:  6     ISSN:  1535-7163     ISO Abbreviation:  Mol. Cancer Ther.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-19     Completed Date:  2007-11-09     Revised Date:  2011-07-01    
Medline Journal Info:
Nlm Unique ID:  101132535     Medline TA:  Mol Cancer Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  496-505     Citation Subset:  IM    
Experimental Therapeutics Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Building 10, Room 13N240, MSC 1903, Bethesda, MD 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenoviridae Infections / drug therapy,  metabolism,  virology
Adenoviruses, Human / genetics*
Antibiotics, Antineoplastic / pharmacology*
Blotting, Western
Depsipeptides / pharmacology*
Green Fluorescent Proteins / genetics,  metabolism
Histone Deacetylase Inhibitors*
Histones / metabolism
Melanoma / drug therapy*,  metabolism,  virology
Mice, Nude
RNA, Messenger / genetics,  metabolism
RNA, Viral / genetics,  metabolism
Receptors, Virus / genetics,  metabolism
Reverse Transcriptase Polymerase Chain Reaction
Skin Neoplasms / drug therapy*,  metabolism,  virology
Transgenes / drug effects*
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/CXADR-like membrane protein; 0/Depsipeptides; 0/Histone Deacetylase Inhibitors; 0/Histones; 0/RNA, Messenger; 0/RNA, Viral; 0/Receptors, Virus; 0/enhanced green fluorescent protein; 128517-07-7/romidepsin; 147336-22-9/Green Fluorescent Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II.
Next Document:  The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.